Detailed pedigree analyses and prenatal diagnosis for a family with mucopolysaccharidosis type II,BMC Medical Genomics

当前位置： X-MOL 学术 › BMC Med. Genomics › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Detailed pedigree analyses and prenatal diagnosis for a family with mucopolysaccharidosis type II
BMC Medical Genomics ( IF 2.7 ) Pub Date : 2021-06-30 , DOI: 10.1186/s12920-021-01027-5
Chuan Zhang _{1,

2} , Shengju Hao ₁ , ZhaoYan Meng ₁ , Ling Hui ₁ , Yan Wang ₁ , Feng Xuan ₁ , Xue Chen ₁ , Xing Wang ₁ , Furong Zheng ₁ , Lei Zheng ₁ , Bingbo Zhou ₁ , Xinqi Wu ₁ , Qinghua Zhang ₁ , Zongfu Cao ₂

Affiliation

Mucopolysaccharidosis type II (MPS II) is an X-linked multisystem disorder caused by mutations in the gene encoding iduronate 2-sulfatase (IDS). The clinical manifestations of MPS II include skeletal deformities, airway obstruction, cardiomyopathy, and neurologic deterioration. MPS II has high genetic heterogeneity disorder, and ~ 658 variants of IDS have been reported. We undertook a detailed pedigree analysis of four patients within the same family by targeted next-generation sequencing and Sanger sequencing. We identified a novel heterozygous frameshift variant, c.1224delC(p.Pro408ProfsTer31), of IDS in three patients. We defined c.1224delC as a pathogenic variant according to the 2015 guidelines set by the American College of Medical Genetics and Genomics. We reported the second Chinese female MPS II patient. We helped to ensure that these two families had healthy babies. Our findings have enlarged the mutational spectrum of IDS, and these findings could be useful for genetic counseling and the prenatal diagnosis of MPS II.

更新日期：2021-06-30

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>